John Cadwell, MS
HFBR Platform Advisor
John James Stewart Cadwell, an innovative leader in the biotechnology industry, serves as the President and CEO of FiberCell Systems Inc. Since founding the company in 2000, he has been instrumental in designing, developing, and supporting an extensive line of laboratory-scale hollow fiber bioreactor systems. These systems are pivotal in the culture of mammalian cells, insect cells, and for pharmacokinetic and pharmacodynamic (Pk/Pd) studies on pathogenic bacteria and antibiotics.
A key figure in the biotechnology sector, Cadwell has a track record of pioneering achievements, including the launch of a new line of magnetic beads for cell separation and the development of stem cell isolation protocols. His innovative approach led to the doubling of electrophoresis equipment sales in the Southeast over a two-year period and conceptualizing a comprehensive biotechnology program for a distributor. He is also credited with three patents covering a production-scale hollow fiber bioreactor.
Cadwell's diverse employment experience includes significant roles such as Sales Representative at Cellco Advanced Bioreactors Inc., where he was responsible for national sales activities and achieved a 25% annual growth in sales. He also worked at Immunicon Corporation, focusing on sales and application development for immunomagnetic beads for cell separation.
As a Product Manager at Curtin Matheson Scientific and Gelman Sciences, Cadwell conceptualized and created a complete biotechnology product offering and marketing support, negotiating distribution deals with new suppliers and managing clinical electrophoresis products. Cadwell's educational background includes an M.S. in Pharmacology from the University of Miami School of Medicine and a B.S. in Biology/Psychology from Luther College, along with international research experiences at the University of Nottingham and the National Institute of Medical Research in the UK. He is a member of several prestigious organizations, including the Nijmegen Consortium for Non-cellular Messenger RNA Therapies and the International Society for Extracellular Vesicles.
Cadwell's extensive list of publications includes white papers on hollow fiber bioreactor systems and book chapters, contributing significantly to the field's body of knowledge. He holds multiple patents related to cell growth technologies, demonstrating his innovative capabilities in the biotechnology field. Cadwell's expertise and leadership have been pivotal in advancing biotechnology and bioprocessing, making significant contributions to the field of cell culture and bioreactor systems.